Document Detail


Beta-lactam antibiotics during pregnancy: a cross-sectional comparative study Zagreb-Novi Sad.
MedLine Citation:
PMID:  22338555     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVES: During pregnancy, a number of changes occur in women's body, and some medications are safe and some are not. The aim of our study was to establish the possible correlation between use of beta-lactam antibiotics in pregnancy and occurrence of congenital malformations.
MATERIAL AND METHODS: The study included 893 pregnant women from Zagreb and 6099 pregnant women from Novi Sad. 527 pregnant women used beta-lactams. First part of the study (one month study) was performed at four maternity hospitals in Zagreb, Croatia. Second part were collected as a part of the study analysing the teratogenicity of drugs used in pregnancy, a longitudinal study performed in Novi Sad district.
RESULTS: Pregnant women most frequently used antibacterial agents in the first trimester of pregnancy. They used 15 different antibacterial medications, most often beta-lactams. In Zagreb arm, out of the total number of pregnant women that used medications during pregnancy (859), 231 (26.9%) used beta-lactam antibiotics. Malformations were detected in 8 (3.5%) cases. The prevalence of malformations in newborns whose mothers did not take beta-lactam antibiotics in pregnancy (662) was 2.7% (18 newborns with malformations). In Novi Sad arm, out of the total number of pregnant women that used medications during pregnancy (2013), 296 (14.7%) used beta-lactam antibiotics. Malformations were detected in 14 (4.7%) cases. The prevalence of malformations in newborns whose mothers did not take beta-lactam antibiotics in pregnancy (5803) was 1.7% (99 newborns with malformations).
DISCUSSION: The results show possible teratogenic potential even with those antibacterials which are considered safe (amoxicillin) but as those are usually minor malformations they often pass undetected. International pharmacoepidemiological studies of drug use in pregnancy could substantially contribute to the improvement of pharmacotherapy, and could be of great help in assessing the fetal risks.
Authors:
M Erić; M Leppée; A Sabo; J Culig
Related Documents :
16601595 - The risk of neuro-orthopaedic malformations following in-vitro fertilization.
7793035 - Suitability of the intact acrosome method for the prediction of fertility in bovine art...
7308525 - Fertility and ovum transport after microsurgical removal of the uterotubal junction in ...
2303155 - Reinsemination in human ivf with fresh versus initial semen: a comparative study.
25382635 - Insufficient vitamin d supplement use during pregnancy and early childhood: a risk fact...
9271955 - Preventing teen pregnancy. it's time to stop kidding around.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European review for medical and pharmacological sciences     Volume:  16     ISSN:  1128-3602     ISO Abbreviation:  Eur Rev Med Pharmacol Sci     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-02-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9717360     Medline TA:  Eur Rev Med Pharmacol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  103-10     Citation Subset:  IM    
Affiliation:
Department of Anatomy, School of Medicine, University of Novi Sad, Novi Sad, Serbia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy...
Next Document:  Suprapubic percutaneous sclero-embolization of symptomatic female pelvic varicocele under local anes...